Amino Acid Substitutions in Gag Protein at Non-cleavage Sites Are Indispensable for the Development of a High Multitude of HIV-1 Resistance against Protease Inhibitors-Reference-Cited by-同舟云学术

Amino Acid Substitutions in Gag Protein at Non-cleavage Sites Are Indispensable for the Development of a High Multitude of HIV-1 Resistance against Protease Inhibitors

Published:2002-02 Issue:8 Volume:277 Page:5952-5961
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Gatanaga Hiroyuki,Suzuki Yasuhiro,Tsang Hsinyi,Yoshimura Kazuhisa,Kavlick Mark F.,Nagashima Kunio,Gorelick Robert J.,Mardy Sek,Tang Chun,Summers Michael F.,Mitsuya Hiroaki

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference31 articles.

1. Textbook of AIDS Medicine;Mitsuya,1999

2. JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1

3. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

4. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and virologic mechanism of the emergence of resistance to M ^pro inhibitors in SARS-CoV-2;Proceedings of the National Academy of Sciences;2024-09-05

2. HIV-1 envelope facilitates the development of protease inhibitor resistance through acquiring mutations associated with viral entry and immune escape;Frontiers in Microbiology;2024-04-18

3. Potential Associations of Mutations within the HIV-1 Env and Gag Genes Conferring Protease Inhibitor (PI) Drug Resistance;Microbiology Research;2021-12-15

4. HIV-1 Gag Non-Cleavage Site PI Resistance Mutations Stabilize Protease/Gag Substrate Complexes In Silico via a Substrate-Clamp;BioChem;2021-11-05

5. Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes;Antimicrobial Agents and Chemotherapy;2021-02-17